Glutamate is the major excitatory neurotransmitter in a mammal’s central nervous system. It is an important component for neuroplasticity, the synaptic communication between neurons. It’s also key to learning and memory. But in high concentrations, glutamate becomes toxic– over-exciting the neurons. Glutamate-induced excitotoxicity is known to exacerbate damage caused by brain injury, stroke and other neurodegenerative diseases.
In order to understand possible ways to reduce the damage of excessive glutamate, researchers at Georgetown University Medical Center have shown how, when high concentrations of glutamate activate the metabotropic glutamate receptor 1 (mGlu1 receptors), they become protective. This concentration of glutamate is normally toxic.
The study, presented at the 39th annual meeting of the Society for Neuroscience, suggests that this glutamate-induced protection occurs due to the association of mGlu1 receptors with the intracellular protein β-arrestin, which causes a sustained phosphorylation of mitogen-activated protein kinases, and protects cells from apoptotic death.
“Studies about the signal transduction involved in mGlu1-mediated neuroprotection may enhance our understanding of the role that this glutamate receptor plays in brain injury,” explains Andrew Emery, a PhD candidate in the Interdisciplinary Program in Neuroscience at GUMC. “Such studies may contribute to rational drug design for potential therapeutic approaches to protect against excitotoxic brain damage following injury, stroke and neurodegenerative diseases.
The study was funded by grants from the National Institute of Neurological Disorders and Stroke. The authors report no related financial interests.
About Georgetown University Medical Center
Georgetown University Medical Center is an internationally recognized academic medical center with a three-part mission of research, teaching and patient care (through Georgetown’s affiliation with MedStar Health). GUMC’s mission is carried out with a strong emphasis on public service and a dedication to the Catholic, Jesuit principle of cura personalis – or “care of the whole person.” The Medical Center includes the School of Medicine and the School of Nursing and Health Studies, both nationally ranked, the world-renowned Lombardi Comprehensive Cancer Center and the Biomedical Graduate Research Organization (BGRO), home to 60 percent of the university’s sponsored research funding.
Karen Mallet (media only)